Literature DB >> 35839163

Risk factors for HCV transmission in HIV-positive men who have sex with men in México.

José Antonio Mata-Marín1, Armando Abraham de Pablos-Leal1, Stefan Mauss2, Carla Ileana Arroyo-Anduiza3, Mara Soraya Rodríguez-Evaristo4, Luis Antonio Uribe-Noguéz5, María de Los Ángeles Berrospe-Silva6, Juan Carlos Lara-Castañeda7, Edgar Pérez-Barragán8, Jesús Gaytán-Martínez1.   

Abstract

PURPOSE: In the last two decades transmission of hepatitis C virus (HCV) in HIV positive men who have sex with men (MSM) has been reported globally. Chemsex and specific sexual practices have been identified as risk factors. Our study aimed to identify risk factors for HCV transmission in MSM living with HIV attending in Mexico.
METHODS: We conducted a case-control study from April to December 2019 at the Hospital de Infectología "La Raza" National Medical Center, in Mexico City. A case was defined as an HIV-infected MSM with positive HCV-antibody test. For each case, 3 controls were included, defined as HIV infected MSM with negative HCV-antibody test. A self-questionnaire covering sexual practices and other risk factors for HCV transmission was applied. Bivariate analysis was performed to obtain odds ratio (OR) using Chi-square test. Independent risk factors were identified in a subsequent analysis performing a logistic regression model.
RESULTS: A total of 324 patients participated in the study, 81 cases and 243 controls. Median age was 30.5 years (IQR: 18-52) and 28.8 years (IQR: 21-45) in the case and control group, respectively. Most prevalent HCV genotype was 1a (79%). In the logistic regression model, sharing straw during cocaine inhalation (OR: 9.03; 95% CI; 1.35-13.52; P = 0.003), sharing sex toys (OR: 17.53, 95% CI; 6.85-44.86; P = 0.002), and ethyl chloride use for chemsex (OR: 2.26; 95% CI; 1.29-5.56; P = 0.037) were significant risk factors for HCV infection.
CONCLUSION: This study identifies risk factors for HCV transmission in Mexico in HIV positive MSM in congruence with the findings of many studies performed worldwide. This is the first study that indicates a possible association between ethyl chloride use in chemsex and HCV infection. Assessment of local populations for risk factors for HCV transmission may help to develop specifically targeted behavioral interventions to reduce HCV transmission.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35839163      PMCID: PMC9286238          DOI: 10.1371/journal.pone.0269977

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


Introduction

Globally more than 71.1 million people are infected with hepatitis C virus (HCV) [1], and 38 million people with human immunodeficiency virus (HIV), Mexico however, has a low HIV prevalence in adults (0.54%) [2, 3]. HCV is primarily transmitted through percutaneous exposure to blood, owing to medical procedures or sharing contaminated devices for injection drug use (IDU) [4]. Over the last 2 decades, effective harm reduction practices have contributed to the minimization of HIV transmission in IDU, thereby concomitantly reducing exposure to HCV. However, HCV infection in non-IDU men who have sex with men (MSM), has been on the rise at the same time and gained increasing attention [5]. Sexual transmission of HCV has emerged as a risk factor for HCV infection since 2000 in MSM particularly in HIV-positive individuals [6]. Certain sexual practices involving trauma of the rectal mucosa have been discussed as relevant risk factors for transmission among MSM. A German study involving 34 cases and 67 controls identified frequent rectal trauma with bleeding, receptive fisting without gloves, group sex, use of sex toys and nasally administered drugs [7, 8]. Another risk factor identified in the prospectively recruited MACS cohort (Multicenter AIDS Cohort Study) was an association between HCV seropositivity and enema use before receptive anal intercourse [9]. Mucosal ulcerative sexually transmitted infections (STIs) such as syphilis may also facilitate HCV acquisition through disrupting mucosal integrity [10]. There is also evidence that “chemsex”, defined as the voluntary intake of certain psychoactive and non-psychoactive drugs in the context of sex parties and sexual intercourses with the intention of facilitating and/or enhancing the sexual encounter, mostly among men who have sex with other men, is associated with HCV sexual transmission [Curr Neuropharmacol. 2017 ">11-15]. The findings show the importance of screening HIV-infected MSM for HCV, particularly those engaged in high-risk sexual behavior. In addition, understanding specific risk factors for HCV transmission, which may vary in the local MSM population, is important for behavioral interventions. The aim of this study was to identify the risk factors for HCV infection in HIV positive MSM in Mexico City.

Methods

Design

A case-control study 1:3 was conducted from April to December 2019, in patients treated at the Hospital de Infectología “La Raza” National Medical Center, Mexico City. The HIV clinic is a third level reference center for people with social security coverage. Only male patients attend and patients are frequently referred for initiation of antiretroviral therapy and relocated to their local clinics after completing the first treatment period. The study was approved by the local committee for health research 0350 at the Hospital de Infectología “La Raza” National Medical Center, with registration number R-2810-003-002. Written informed consent was obtained from all participants before answering a risk factors questionnaire.

Study population

Study subjects were HIV-infected MSM ≥18 years old. For this study, a case-patient was defined as an HIV-infected MSM evaluated at National Medical Center “La Raza”, who had a positive HCV-antibody test result. For each case-patient, 3 controls were included, defined as HIV infected MSM who had a negative HCV-antibody test. We retested all cases with HCV antibody test (ELISA) and HCV RNA.

Measurements

Information was obtained in an anonymous 44-item self-questionnaire covering sexual behavior, use of illicit or recreational drugs and diagnoses of STIs. We used a modified version of the questionnaire of Zuure et al., and added some risk factors like chemsex and drugs that are common in Mexico for recreational drug use [16, 17] S1 Appendix. For example, ethyl chloride can be easily accessed in drug stores and is therefore frequently used in Mexico. In addition, clinical data were collected as following: previous serological diagnosis of syphilis, diagnosis of urethritis, genital ulcers, proctitis, HBV infection and antiretroviral therapy (ART). The laboratory results performed in cases and controls were CD4+ cell count, HIV RNA and in HCV cases, HCV RNA and HCV genotype. We used Architect anti‐HCV assay (Abbott, Wiesbaden, Germany) for HCV antibody testing and Abbott RealTime HCV (Abbott Molecular Inc., Des Plaines, IL, USA) for quantitative HCV RNA.

Statistical analysis

The sample size was calculated with an 95% confidence level and an 80% of power, using a formula for unmatched Case-Control studies. In the case of non-normal distributions, we used the Kolmogorov Smirnov test. Descriptive results were summarized using median and interquartile ranges (IQR). Bivariate analysis was performed to evaluate the risk factors for HCV transmission and to obtain the odds ratio (OR) using the Chi-square test and Fisher’s exact test. Independent risk factors associated with HCV transmission were identified in the logistic regression analysis (calculated with 95% confidence intervals) which included the significant variables (p<0.05) from the bivariate analysis. All analyses were conducted using SPSS software (version 22; SPSS IBM Corp., Armonk, NJ, USA).

Results

Of the 337 patients invited to participate in the study, 81 cases and 243 controls agreed to participate and 13 declined the invitation. The median age was 30.5 years (IQR: 18–52) for cases and 28.8 years (IQR: 21–45) for controls. The median CD4+ cell counts of cases were 498 cells/mm3 and 324 cells/mm3 in the control group. Of the 81 patients of the case group, 63 patients (77.8%) had started HIV treatment, and 18 patients (22.2%) cleared HCV RNA spontaneously ( Abbreviations: ART: Antiretroviral therapy

Risk factors

In bivariate analysis we found that cocaine use (OR: 3.36; 95% confidence interval [CI]1.80–6.27; P, = 0.01), sharing straw during cocaine inhalation (OR: 4.28; 95% CI 1.35–13.52; P = 0.01); marijuana use (OR: 2.10; 95% CI 1.24–3.58; P = 0.005); ethyl chloride use (OR: 2.67; 95% CI 1.29–5.56; P = 0.007) and use of poppers (OR: 2.22; CI 1.33–3.7; P = 0.002) were associated with HCV transmission. Other risk factors associated with HCV transmission were use of sex toys (OR: 1.88; 95% CI; 1.11–3.18; P = 0.018), share sex toys (OR: 6.19; 95% CI 2.33–16.42; P = <0.001), group sex (OR: 1.95; 95% CI 1.11–3.25; P = 0.009), and enemas before sex (OR: 3.2; 95% CI 1.91–5.41: P = <0.001) ( Abbreviations: OR: Odds ratio; 95% CI: 95% confidence interval; HBV: Hepatitis B virus and HPV: Human papillomavirus After entering these variables into a logistic regression model sharing straw during cocaine inhalation (odds ratio [OR]: 9.03; 95% CI; 1.35–13.52; P = 0.003), sharing sex toys (odds ratio [OR]: 17.53, 95% CI 6.85–44.86; P = 0.002), and ethyl chloride use (odds ratio [OR]: 2.26; 95% CI 1.29–5.56; 0.037) remained statistically significant ( Abbreviations: aOR: adjusted odds ratio, 95% CI: 95% confidence interval

Discussion

In this study, risk factors for the transmission of HCV were assessed in a Mexican HIV-positive MSM population. Independent risk factors for HCV transmission were sharing the straw for inhaling cocaine, as well as sharing sex toys that involve penetration. In addition, the use of ethyl chloride during sexual intercourse was also a risk factor for HCV transmission. In general, our findings are in agreement with studies from Germany, UK, Japan, France and New York showing that risk factors for transmission of HCV were sex practices involving rectal trauma that leads to bleeding, receptive fisting without the use of gloves, group sex, inhaling cocaine or methamphetamine, receptive anal sex without protection and the use of sex toys [5, 6, 16, 18]; these observations were also supported by a French cohort identifying similar risk factors [19]. In contrast to the studies above, we were not able to find an association between receptive anal sex and HCV infection. Cocaine was only a risk factor when sharing the straw [20]. Using ethyl chloride in chemsex is common in Mexico and may a regional phenomenon and because of this not reported in other studies so far [21]. Sex toys can cause dilation of anal tissue and micro-bleeding during sexual activity and promote HCV transmission by this [22, 23]. It has been suggested that HCV is also transmitted by the toy itself by sharing contaminated sex toys [7, 24]. Indeed, we found an association between sharing sex toys and HCV transmission. However, as case patients may have attributed the use of sex toys with acquiring HCV infection a recall bias compared to uninfected controls cannot be excluded. In contrast to other studies rectal douching and sexually transmitted infections associated with mucosal ulceration (mainly syphilis) were not associated with transmission of HCV infection in our study [25-33]. This may be partially explained by the fact that we used a VDRL as a surrogate marker for syphilis which cannot discriminate between active ulceration and past infection. This is the first study carried out in Mexico assessing risk factors for HCV transmission in HIV-positive MSM. Unlike in most other studies, detailed information on a number of risk factors including many substances used in chemsex, as well as other sexually transmitted infections and behavioral factors were assessed in the questionnaire. Our study has several limitations, mostly by design. It is a case-control study, retrospective analysis performed in a single hospital. Another limitation is that we were not able to pair cases and controls by age or any other characteristic, because HCV/HIV coinfection prevalence in Mexico is low. Correlated variables, e.g., inhaling cocaine and sharing a straw to inhale cocaine or the use of sex toys and sharing sex may affect the precision of the regression model this has to be considered for the result interpretation. To our knowledge, this is the first study reporting a possible association between ethyl chloride and HCV infection. The reason could be that ethyl chloride is a cheap product and can be easily accessed in drug stores and supermarkets. In general, the study highlights the necessity to screen HIV-positive MSM for HCV infection. Some of these risk factors could be mitigated by safer practices such as not sharing cocaine straws or sex toys. Assessment of local populations for the main risk factors for HCV transmission may help to develop specifically targeted behavioral interventions to reduce HCV transmission.

Risk factors for HCV transmission in HIV-positive men who have sex with men self-questionnaire.

(DOCX) Click here for additional data file.
Table 1

Characteristics of the study population.

Cases (81)Controls (243) p-value
Age, median (IQR), years30.5 (18–52)28.8 (21–45)0.54
CD4+, median (IQR) cells/mm3498 (285–674)324 (212–499)<0.001
HIV viral load, median (IQR), copies/ mm351 (40–47347)15426 (6321–89363)<0.001
HCV viral load, median (IQR), copies/mm94326 (50–514500)
HCV seroconversion while on ART, n (%)18 (22.2)
Receiving ART, n (%)46 (56.7)11 (4)
Genotype, n (%)
    1a, n (%)50 (79.3)
    1b, n (%)3 (4.7)
    2b, n (%)6 (9.5)
    4, n (%)2 (3.1)
    1a/4, n (%)2 (3.1)

Abbreviations: ART: Antiretroviral therapy

Table 2

Risk factors bivariate analysis.

Risk FactorOR95%CIP Value
Age (>40 years)3.421.75–6.71<0.001
IV Drugs2.631.05–6.60.03
>5 Sex partners1.030.60–1.780.89
Tattoos1.180.71–1.980.51
Piercing1.941.1–3.20.01
Surgery1.550.68–1.950.59
Dental surgery0.820.49–1.350.44
Colonoscopy1.870.82–4.270.13
Acupuncture0.080.40–1.950.76
Prision record0.590.06–5.160.63
Chemsex1.520.91–2.560.17
Cocaine3.361.80–6.270.01
Sharing straw for cocaine inhalation4.281.35–13.520.01
Use of gamma hydroxybutyrate (GHB)2.050.56–7.460.26
Use of ketamine6.21.12–34.840.01
Use of ecstasy1.990.06–4.600.09
Use of marijuana2.101.24–3.580.005
Use of methamphetamine2.091.01–4.320.04
Use of poppers2.221.33–3.70.002
Use of ethyl chloride2.671.29–5.560.007
Alcohol use1.851.04–3.290.03
Use of phosphodiesterase 5 inhibitors1.280.67–2.450.44
Insertive fisting1.340.53–3.380.53
Receptive fisting1.080.44–2.440.91
Use of sex toys1.881.11–3.180.018
Share Sex Toys6.192.33–16.42<0.001
Group Sex1.951.11–3.250.009
Enemas previous to sex (rectal douching)3.21.91–5.41<0.001
Syphilis1.460.85–2.500.16
Urethritis1.550.84–2.870.15
HBV0.960.45–2.060.92
HPV0.850.45–1.620.63
Ulcerative genital infection1.300.69–2.40.40
Proctitis1.470.63–3.400.36

Abbreviations: OR: Odds ratio; 95% CI: 95% confidence interval; HBV: Hepatitis B virus and HPV: Human papillomavirus

Table 3

Multivariate analysis.

Risk factorsaOR95%CIP value
• Sharing straw for cocaine inhalation9.031.35–13.520.003
• Sharing Sex Toys17.536.85–44.860.002
• Ethyl chloride2.261.29–5.5630.037

Abbreviations: aOR: adjusted odds ratio, 95% CI: 95% confidence interval

  31 in total

Review 1.  Sexually acquired hepatitis C virus infection: a review.

Authors:  Denise P C Chan; Hsin-Yun Sun; Horas T H Wong; Shui-Shan Lee; Chien-Ching Hung
Journal:  Int J Infect Dis       Date:  2016-06-03       Impact factor: 3.623

2.  Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017.

Authors:  B Hampel; K Kusejko; R D Kouyos; J Böni; M Flepp; M Stöckle; A Conen; C Béguelin; P Künzler-Heule; D Nicca; A J Schmidt; H Nguyen; J Delaloye; M Rougemont; E Bernasconi; A Rauch; H F Günthard; D L Braun; J Fehr
Journal:  HIV Med       Date:  2019-12-18       Impact factor: 3.180

Review 3.  Global Epidemiology of Viral Hepatitis.

Authors:  Homie Razavi
Journal:  Gastroenterol Clin North Am       Date:  2020-06       Impact factor: 3.806

4.  Evaluation of hepatitis C testing in men who have sex with men, and associated risk behaviours, in Manchester, UK.

Authors:  G Ireland; S Higgins; B Goorney; C Ward; S Ahmad; C Stewart; R Simmons; S Lattimore; V Lee
Journal:  Sex Transm Infect       Date:  2017-01-27       Impact factor: 3.519

5.  Evaluation of a risk assessment questionnaire to assist hepatitis C screening in the general population.

Authors:  F Zuure; U Davidovich; G Kok; A C Depla; C Hoebe; A van den Hoek; P L Jansen; P van Leeuwen-Gilbert; C J Weegink; R A Coutinho; M Prins
Journal:  Euro Surveill       Date:  2010-04-15

6.  Hepatitis C virus infection and its relationship to certain sexual practices in men-who-have-sex-with-men in Spain: results from the European MSM internet survey (EMIS).

Authors:  Percy Fernández-Dávila; Cinta Folch; Laia Ferrer; Raúl Soriano; Mercedes Diez; Jordi Casabona
Journal:  Enferm Infecc Microbiol Clin       Date:  2014-10-30       Impact factor: 1.731

Review 7.  Acute hepatitis C in patients with HIV.

Authors:  Christoph Boesecke; Jürgen Kurt Rockstroh
Journal:  Semin Liver Dis       Date:  2012-07-03       Impact factor: 6.115

8.  Risk factors for HCV acquisition among HIV-positive MSM in Belgium.

Authors:  Ludwig Apers; Wim Vanden Berghe; Stéphane De Wit; Kabamba Kabeya; Steven Callens; Jozefien Buyze; Christopher Kenyon; Eric Florence; Anne Buvé
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-15       Impact factor: 3.731

9.  Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours.

Authors:  Mark Danta; David Brown; Sanjay Bhagani; Oliver G Pybus; Caroline A Sabin; Mark Nelson; Martin Fisher; Anne M Johnson; Geoffrey M Dusheiko
Journal:  AIDS       Date:  2007-05-11       Impact factor: 4.177

10.  Gaining greater insight into HCV emergence in HIV-infected men who have sex with men: the HEPAIG Study.

Authors:  Christine Larsen; Marie-Laure Chaix; Yann Le Strat; Annie Velter; Anne Gervais; Isabelle Aupérin; Laurent Alric; Xavier Duval; Patrick Miailhes; Corinne Pioche; Stanislas Pol; Lionel Piroth; Elisabeth Delarocque-Astagneau
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.